Anti TIM 3 antibodies are disclosed as well as pharmaceutical compositions comprising such antibodies and uses and methods using the same such as in the treatment of cancer infectious diseases or T cell dysfunctional disorders. Bispecific antibodies against TIM 3 and other targets are also disclosed with preferred embodiment of a bispecific antibody against TIM 3 and CD3.